CBD LIFE SCIENCES INC - CBDL STOCK NEWS

CBD Life Sciences Inc. (OTC PINK:CBDL) has signed a Memorandum of Understanding (MOU) with a large mushroom supplement company. This partnership aims to expand CBDL's revenue opportunities beyond CBD into the adaptogenic mushroom market. Adaptogenic mushrooms are known for potentially helping the body respond to stress, anxiety, fatigue, and overall well-being, without psychoactive effects.

The CBD Vault Inc., a wholly-owned subsidiary of CBDL, offers a full line of cannabidiol-based and organic products, including Delta 8 & 10 Gummy's, Full Spectrum Tinctures & Gummy's, Pain Cream, and various other CBD-infused items. These products are available for retail and wholesale purchase through the company's website, www.thecbdvault.com.

CBD Life Sciences Inc. (OTC PINK:CBDL) has announced an expansion into Sedona, Arizona, a major tourist destination with approximately 3 million annual visitors. This move is expected to drive revenue growth and increase brand exposure. The company's products will be available in various local establishments, including:

• Vape stores
• Spas
• Holistic stores
• Nail salons
• Pet shops (offering pet treats)

CBDL also stated that it has no plans for future reverse splits and is focusing on organic revenue growth. The company hinted at upcoming international partnerships and the possibility of reducing authorized share count or buying back shares if market conditions are favorable.

CBD Life Sciences Inc. (OTC PINK:CBDL) has announced an increased revenue projection for 2025, forecasting $1.8 million in sales for its CBD Vault™ brand. This upward revision is attributed to anticipated organic growth and expected revenue contributions from recently added sales channel partners. The company is also exploring opportunities to establish operating partnerships on a more national scale.

Lisa Nelson, CEO of CBDL, expressed satisfaction with the reception of the CBD Vault™ brand, noting its role in gaining traction and visibility in the competitive CBD products market. The company aims to leverage this increased visibility to secure stronger sales channel partners, which will drive future sales objectives.

CBD Life Sciences Inc. (OTC PINK:CBDL) has increased its 2025 revenue projection to $1.8 million for its CBD VaultTM brand sales. This forecast is based on anticipated organic growth and expected revenue from recently added sales channel partners. The company is also exploring opportunities to establish operating partnerships on a national scale.

CEO Lisa Nelson expressed satisfaction with the CBD VaultTM brand's reception, noting its role in gaining traction and visibility in the competitive CBD products market. CBDL aims to leverage this increased visibility to secure stronger sales channel partners, which will drive future sales objectives.

CBD Life Sciences Inc. (OTC PINK:CBDL) has announced the appointment of Jennifer Simmons as the new General Manager. With over 10 years of experience in marketing and business development, Jennifer brings a wealth of expertise to CBDL. Her background includes working with major companies like Square Inc., TNT Fireworks, and Capital One.

In her new role, Jennifer will oversee the opening of multiple retail locations, manage the Scottsdale location, lead the sales team, and drive both in-store and online traffic. Her appointment is expected to significantly boost CBDL's growth, revenue, and marketing strategies.

CBDL, a leading company in the CBD industry, continues to focus on the potential benefits of CBD for various health conditions, including neurological disorders, pain management, and gastrointestinal health.

CBD Life Sciences Inc. (OTC PINK:CBDL) has announced a significant partnership between its subsidiary, The CBD Vault Inc, and Sunset Wholesale West, Arizona's largest CBD wholesaler. This collaboration will see The CBD Vault's pain creams, athlete-specific pain relief roll-ons, and gummies distributed through Sunset Wholesale's extensive network.

Sunset Wholesale, established in 2004, operates from a 40,000-square-foot warehouse and carries over 12,000 products. Lisa Nelson, President & CEO of The CBD Vault, expressed enthusiasm about the partnership, highlighting its potential to enhance market penetration and drive substantial revenue growth.

The partnership aligns with The CBD Vault's mission to provide accessible, high-quality CBD products, which are known for their potential benefits in addressing various conditions, including neurological disorders, pain management, and gastrointestinal health issues.

CBD Life Sciences Inc. (OTC PINK:CBDL) has announced a major distribution milestone for its subsidiary, The CBD Vault Inc. The company's high-strength CBD Pain Relief Cream is now available at the prestigious Red Hots Spa in Roslyn and Garden City, NY. This strategic partnership is expected to enhance brand visibility and accessibility in a key market.

The CBD Pain Relief Cream, containing 3000mg of premium CBD, is designed for muscle, joint, and chronic pain relief. It comes in various scents, including Coconut Mango and Green Tea & Lemongrass. CEO Lisa Nelson projects a 20-30% revenue increase over the next quarter due to this placement, aligning with the company's goals of market expansion and increasing investor value.

CBD Life Sciences (OTC PINK:CBDL) has launched a new line of Kava & Kratom shots through its subsidiary, The CBD Vault.

These shots are crafted using high-quality natural ingredients for a safe and effective experience.

They come in a sleek, portable bottle, making them convenient for on-the-go use.

The formulation offers a balanced blend of Kava and Kratom for energy and relaxation, available in a delicious apple flavor.

CBD Life Sciences (CBDL) announced the launch of Delta 8 CBD Vape Cartridges. These premium cartridges come in four flavors—Bubba Kush, Watermelon Zkittles, Purple Punch, and Mimosa—offering enhanced therapeutic benefits like stress relief, pain management, and improved sleep quality. The launch is expected to drive a 50% sales increase in the first six months. With the global CBD market projected to reach $13.4 billion by 2028, and vape products being a fast-growing segment, CBDL aims for a strong market position with its full-spectrum, high-quality offerings.